Company profile for Evonik

PharmaCompass

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Related CompaniesRelated Companies

About

Evonik is one of the world leaders in specialty chemicals.
The company is active in >100 countries around the world & generated sales of €15.3 billion & an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik is one of the world’s largest CDMOs with capabilities to manufacture customized APIs & HPAPIs. To address the specific needs of large or complex projects, they have established a broad portfolio of differentiating technologies. These technologies include catalytic & biocatalytic reactions, large-scale cryogenic chemistry, continuous processing, fermentation, PEGs & mPEGs, catalysts, & polymer APIs.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Rellinghauser Straße 1-11, Essen, NRW 45128, DE
Telephone
Telephone
+49 20117701
Contact Info
Others

Events

Webinars & Exhibitions

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $tile1

Filename: tabs/exhibitions.php

Line Number: 43

Backtrace:

File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler

File: /var/www/html/application/models/CmnPec.php
Line: 1625
Function: view

File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create

File: /var/www/html/application/views/include/party/indexNew.php
Line: 70
Function: include

File: /var/www/html/application/views/commonNew.php
Line: 445
Function: include

File: /var/www/html/application/controllers/PharmaServices.php
Line: 4651
Function: view

File: /var/www/html/index.php
Line: 224
Function: require_once

CPHI Middle east

CPHI Middle east

Not Confirmed

envelop Contact Supplier

CPHI Middle east

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

CORPORATE CONTENT #SupplierSpotlight

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-29359.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-45011.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-33070.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-34857.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-43828.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-18238.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-party-content-92779.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-63649.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-50971.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-63516.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-1654232250.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-1642841488.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-1642841177.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-1642841094.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-1642841044.pdf

    https://www.pharmacompass.com/pdf/party/content/evonik-industries-party-content-1642838881.pdf